The Technical Analyst
Accuray Inc [ARAY]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Accuray Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
1.40% $2.17
America/New_York / 22 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 215.20 mill |
| EPS: | -0.150 |
| P/E: | -14.47 |
| Earnings Date: | Apr 30, 2024 |
| SharesOutstanding: | 99.17 mill |
| Avg Daily Volume: | 0.469 mill |
| RATING 2024-04-22 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -14.47 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.07x |
| Company: PE -14.47 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-1.500 (-169.14%) $-3.67 |
| Date: 2024-04-23 |
| Expected Trading Range (DAY) |
|---|
|
$ 2.07 - 2.28 ( +/- 4.84%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-01 | Hoge Michael | Sell | 11 991 | Common Stock |
| 2024-01-03 | Pervaiz Ali | Sell | 2 116 | Common Stock |
| 2024-01-03 | Corradetti Gina | Sell | 14 129 | Common Stock |
| 2023-11-30 | Kill Robert | Buy | 56 603 | Common Stock |
| 2023-12-01 | Spine Patrick | Sell | 14 832 | Common Stock |
| INSIDER POWER |
|---|
| 71.49 |
| Last 97 transactions |
| Buy: 4 953 101 | Sell: 644 284 |
Forecast:
16:00 - $2.17
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $2.17
Forecast 2: 16:00 - $2.17
Forecast 3: 16:00 - $2.17
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.17 (1.40% ) |
| Volume | 1.240 mill |
| Avg. Vol. | 0.469 mill |
| % of Avg. Vol | 264.28 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ARAY
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:29 | buy | $2.48 | N/A | Active |
|---|
ARAY
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
Latest Press Releases
2024-04-18 07:35:00 - Press Release
Accuray Expands Global Training Center Network With Opening Of New Facility In Genolier, Switzerland
The new center is the most recent addition to the company's existing training hubs in madison, wisconsin (u.s.), tokyo, japan and tianjin, china each facility offers a range of educational opportunities designed to advance patient care using the accuray cyberknife® and radixact® systems madison, wis., april 18, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that as part of its commitment to advancing patient care the company has opened a new training center in genolier, switzerland, that will serve as the european education hub for radiosurgery and radiotherapy product training, and sharing of best practices and innovative techniques using the latest model accuray cyberknife ® and radixact ® radiation treatment delivery systems and accuray precision ® treatment planning system.
2024-04-17 16:05:00 - Press Release
Accuray To Report Third Quarter Fiscal 2024 Financial Results On May 1, 2024
Madison, wis. , april 17, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) will report financial results for the third quarter of fiscal year 2024, ended march 31, 2024, during a conference call hosted by company management at 1:30 p.m.
2024-03-26 07:35:00 - Press Release
New Data From Two Clinical Studies Indicate High-risk And Recurrent Prostate Cancers Can Be Effectively Treated In 5 Days Using The Accuray Cyberknife® System
Data also underscores potential benefits of cyberknife system sub-millimeter accuracy in preserving quality of life after treatment for prostate cancer madison, wis. , march 26, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that new data presented at the 2024 radiosurgery society meeting in chicago, illinois support the use of the cyberknife ® system in the treatment of high-risk and recurrent prostate cancer.
2024-03-04 16:30:00 - Press Release
Accuray Incorporated To Speak At 36th Annual Roth Conference
Company to take part in fireside chat monday, march 18, 2024 at 12:30pm pst / 3:30pm est madison, wis. , march 4, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today its participation in the 36th annual roth conference.
2024-02-27 17:30:00 - Press Release
Accuray Incorporated To Speak At Oppenheimer 34th Annual Healthcare Medtech & Services Conference
Company to take part in fireside chat tuesday, march 12, 2024 at 7:00am pst / 10:00am est madison, wis. , feb. 27, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today its participation in the oppenheimer 34th annual healthcare medtech & services conference taking place march 12-13, 2024.
Latest News
2024-04-07 00:25:02 - Seeking Alpha
Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp
Despite management guidance that points to significant revenue acceleration in the next two quarters, Accuray shares have languished. Market skepticism can be tied in part to the company's track record - despite multiple efforts to improve its portfolio and go-to-market strategy, market share growth has been very modest. The company's entry into China's Type B market could be its last best chance to change the narrative - meaningful share in a $600M/year market should be transformative.
2024-03-27 13:31:03 - Zacks Investment Research
Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment
Accuray (ARAY) announces the latest data that supports the use of its CyberKnife System in the treatment of recurrent prostate cancer with stereotactic body radiation therapy.
2024-03-20 12:30:20 - Zacks Investment Research
Here's Why You Should Retain Accuray (ARAY) Stock for Now
2024-03-01 12:36:24 - Zacks Investment Research
Accuray (ARAY) Up 1.6% Since Last Earnings Report: Can It Continue?
2024-02-21 14:48:22 - InvestorPlace
7 Screaming Stock Buys for Under $5
While most financial advisors will probably steer you away from under $5 stocks, they have their benefits. Just like in football – the American kind – you can't just run up the gut.
2024-02-20 12:31:15 - Zacks Investment Research
Three Reasons to Retain Accuray (ARAY) Stock in Your Portfolio
The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.
2024-02-01 11:36:05 - Zacks Investment Research
Accuray (ARAY) Q2 Earnings Lag Estimates, Gross Margin Contracts
Despite robust Services revenues, Accuray (ARAY) reports dismal second-quarter fiscal 2024 results.
2024-01-31 22:03:07 - Seeking Alpha
Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript
2024-01-31 19:36:09 - Zacks Investment Research
Accuray (ARAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Accuray (ARAY) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2024-01-30 10:21:32 - Zacks Investment Research
Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Accuray (ARAY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.